Medizia Biotech is a global pharmaceutical manufacturing company specialized in development of innovative pharmaceutical injectable formulations with WHO-GMP & ISO 9001:2015 and DCGI Certified. Our company offering third party manufacturing and PCD pharma franchise opportunities for intensive care products in domestic and international markets. Our products folio made us the choice of many consumers with various products range & good quality control are the strength of Medizia Biotech. Our products are Critical Care Antibiotic Injections, Critical Care Gastroenterology Injection, Critical Care Cardiology Injections, Anti malarial, Analgesics and NSAID Injections which are manufactured under WHO GMP facilities. At our manufacturing unit these Injectable are processed using modern processing techniques and best grade chemical compounds in compliance with defined medical industry standards. Our astute experts test these products against promiscuous quality parameters to ensure their high reliability.
Medizia Biotech is among the few Indian Pharmaceutical companies to has well equipped manufacturing facility for almost all injectable forms. We have Quality Control & Analytical Research Laboratory. That set up to meet the domestic and international quality standards. We have the capability to deliver quality product with established time lines. We have been committed to improving lives.
Our values and expectations are at the heart of everything we do and help define our culture - so that together we can deliver extraordinary things for consumers and make Medizia Biotech a brilliant place to work. Today, we have grown as one of the leading Pharma Company & seamless service provider of India.
Our values are our core. Our values & standards represent the very core of our character as a company.
• Consumer's satisfaction is our priority.
• We have vast critical care range.
• We have Quality Product & Excellent range of products.
Our goal is to discover, develop and provide innovative products and services that save and improve lives around us.
Medizia Biotech has a super modern factory that meets some of the toughest standards of the industry. This means the medicines they make are of very high quality, keeping customers safe and happy.
At Medizia Biotech , the high-quality manufacturing practices come from having really skilled professionals on board. These experts make sure everything meets GMP (Good Manufacturing Practices) standards.they never fail to achieve excellent results for the company.
We offer a diverse portfolio of pharmaceutical products across various segments. This allows our franchise partners to cater to a wide range of healthcare needs and maximize their business potential.
Medizia Biotech makes its own products, so they can sell them at good prices, helping you make more money. They also give you lots of marketing materials and help from their team, making your job easier.
Himanshu Mehandiratta is the Director of Medizia Biotech, a pioneering force in the critical care Manufacturing & Franchise industry. With a rich background in pharmaceutical sciences and business, Himanshu Mehandiratta has steered Medizia Biotech to new heights, focusing on innovation, quality, and global expansion. His leadership is driven by a commitment to improving critical care for patients worldwide, making advanced treatments accessible and fostering a culture of excellence within the company. Himanshu Mehandiratta vision is to create lasting partnerships and advance healthcare outcomes globally.
(Himanshu Mehandiratta)
As the Director of Medizia Biotech, Prince Mehandiratta is a highly respected leader who is dedicated to revolutionizing patient care in the critical care industry. With more than ten years of experience in the pharmaceutical sector, (name)background combines technical knowledge with inspiring leadership. His vision for Medizia Biotech includes not only expanding the company's product portfolio but also fostering a culture of continuous learning and improvement, ensuring that the company remains at the cutting edge of critical care medicine.
(Prince Mehandiratta)